A symposium on recent discoveries in basic and clinical neuroscience and their promise for revolutionary advances in the diagnosis, treatment and prevention of mental illness will be held at Yale School of Medicine (YSM) March 27.
The event, "Towards Recovery from Mental Illness: Integrating Psychiatric Treatments," is aimed at mental health professionals as well as persons affected by mental illness and their families. The symposium will be held in Harkness Auditorium, 333 Cedar St. It will begin at 8 a.m. and adjourn at 1 p.m. There is no charge.
Opening remarks will be delivered by:
* Arthur Evans, deputy commissioner of the Connecticut Department of Mental Health.
* Benjamin Bunney, M.D., chair, Department of Psychiatry, YSM.
* John Krystal, M.D., professor and deputy chair for research, Department of Psychiatry.
* Marilyn Ricci, president of the Connecticut branch of the National Alliance for the Mentally Ill.
Speakers will include:
* Pasko Rakic, M.D., chair and professor, Department of Neurobiology and Dorys McConnell Duberg Professor of Neuroscience, will speak about the developmental hypothesis of schizophrenia.
* D. Cyril D'Souza, M.D., associate professor, psychiatry, will discuss new medications for the treatment of schizophrenia: mechanisms, opportunities, and side effects.
* Robert Rosenheck, M.D., will speak about integrating psychotherapy and services for schizophrenia.
* Bruce Rounsaville, M.D., will discuss integrating psychotherapy and pharmacotherapy for substance use disorders.
* Fred Volkmar, M.D., will talk about understanding the social disability of autism.
* Joan Kaufman, associate professor of psychiatry, will lead a general discussion with the speakers.
In addition to Yale's Connecticut Mental Health Center and Department of Psychiatry, the symposium is sponsored by the state Department of Mental Health and Addiction Services; the Connecticut chapter of the National Alliance for the Mentally Ill, and the Yale Mental Health Education Program. Support was provided by the American College of Neuropsychopharmacology.
Contact
Office of Public Affairs & Communications
203-432-1345